{"id":"https://openalex.org/W2327353149","doi":"https://doi.org/10.4172/2167-1052.s1-007","title":"The Hollow Fiber Infection Model for Antimicrobial Pharmacodynamics and Pharmacokinetics","display_name":"The Hollow Fiber Infection Model for Antimicrobial Pharmacodynamics and Pharmacokinetics","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2327353149","doi":"https://doi.org/10.4172/2167-1052.s1-007","mag":"2327353149"},"language":"en","primary_location":{"id":"doi:10.4172/2167-1052.s1-007","doi":"https://doi.org/10.4172/2167-1052.s1-007","is_oa":true,"landing_page_url":"https://doi.org/10.4172/2167-1052.s1-007","pdf_url":"https://doi.org/10.4172/2167-1052.s1-007","source":{"id":"https://openalex.org/S2765032339","display_name":"Advances in Pharmacoepidemiology & Drug Safety","issn_l":"2167-1052","issn":["2167-1052"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacoepidemiology & Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.4172/2167-1052.s1-007","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065673544","display_name":"John James Stewart Cadwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John J.S. Cadwell","raw_affiliation_strings":["CEO of Fiber Cell Systems Inc. 905 West 7 th Street, #334, Frederick, Md. 21701, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEO of Fiber Cell Systems Inc. 905 West 7 th Street, #334, Frederick, Md. 21701, USA,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5065673544"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.444,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.65553047,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"01","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7343999743461609,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7343999743461609,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.16140000522136688,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hollow-fiber-infection-model","display_name":"hollow-fiber infection model","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hollow-fiber-bioreactor","display_name":"hollow fiber bioreactor","score":0.9139999747276306},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6320000290870667},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.7039999961853027},{"id":"https://openalex.org/keywords/antimicrobial-agents","display_name":"antimicrobial agents","score":0.6010000109672546},{"id":"https://openalex.org/keywords/antibiotics","display_name":"antibiotics","score":0.8769999742507935},{"id":"https://openalex.org/keywords/in-vitro-toxicology","display_name":"in vitro toxicology","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.5180000066757202},{"id":"https://openalex.org/keywords/infection-model","display_name":"infection model","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8356356620788574},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.703386127948761},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6599159836769104},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6024677753448486},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5698512196540833},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23469874262809753},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.20144987106323242}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4172/2167-1052.s1-007","doi":"https://doi.org/10.4172/2167-1052.s1-007","is_oa":true,"landing_page_url":"https://doi.org/10.4172/2167-1052.s1-007","pdf_url":"https://doi.org/10.4172/2167-1052.s1-007","source":{"id":"https://openalex.org/S2765032339","display_name":"Advances in Pharmacoepidemiology & Drug Safety","issn_l":"2167-1052","issn":["2167-1052"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacoepidemiology & Drug Safety","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4172/2167-1052.s1-007","doi":"https://doi.org/10.4172/2167-1052.s1-007","is_oa":true,"landing_page_url":"https://doi.org/10.4172/2167-1052.s1-007","pdf_url":"https://doi.org/10.4172/2167-1052.s1-007","source":{"id":"https://openalex.org/S2765032339","display_name":"Advances in Pharmacoepidemiology & Drug Safety","issn_l":"2167-1052","issn":["2167-1052"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacoepidemiology & Drug Safety","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2327353149.pdf","grobid_xml":"https://content.openalex.org/works/W2327353149.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W116468853","https://openalex.org/W2035031389","https://openalex.org/W2079590704","https://openalex.org/W2098144612","https://openalex.org/W2121019748","https://openalex.org/W2162974067"],"related_works":["https://openalex.org/W4367678449","https://openalex.org/W3034393433","https://openalex.org/W7221420373","https://openalex.org/W7139954621","https://openalex.org/W4285802172","https://openalex.org/W2506454075","https://openalex.org/W4407852503","https://openalex.org/W7147283076","https://openalex.org/W4405644560","https://openalex.org/W4405206827"],"abstract_inverted_index":{"The":[0],"recent":[1],"introduction":[2],"of":[3,15,43,94,132,141],"hollow":[4,95,102,143],"fiber":[5,96,103,144],"bioreactor":[6,97],"cartridges":[7],"represents":[8],"an":[9],"important":[10],"advancement":[11],"in":[12,16,21,112,120,129],"the":[13,44,79,89,92,139,142],"field":[14],"vitro":[17,22,113],"toxicology.Many":[18],"toxicologists":[19],"believe":[20],"testing":[23],"methods":[24,115],"are":[25,47,155],"a":[26,75,85,107],"useful,":[27],"time":[28,53],"and":[29,54,56,81,138,152],"cost":[30],"effective":[31,49],"tool":[32],"for":[33,50],"drug":[34,76,121],"discovery":[35],"but":[36],"it":[37,117,148],"is":[38,63,106,136],"generally":[39],"accepted":[40],"that":[41],"many":[42],"available":[45],"tests":[46],"not":[48,58,67],"examining":[51],"both":[52],"concentration,":[55],"do":[57,66],"closely":[59],"mimic":[60],"human":[61],"kinetics.This":[62],"because":[64],"they":[65,126],"properly":[68],"take":[69],"into":[70],"account":[71],"pharmacodynamic":[72],"actions":[73,83],"(what":[74,84],"does":[77,87],"to":[78,88,110,150],"body)":[80],"pharmacokinetic":[82],"body":[86],"drug).Recently,":[90],"with":[91],"use":[93],"cartridges,":[98],"this":[99],"has":[100],"changed.The":[101],"infection":[104,145],"model":[105,146],"useful":[108],"addition":[109],"standard":[111],"toxicology":[114],"as":[116,125,147],"mimics":[118],"changes":[119],"concentration":[122],"over":[123],"time,":[124],"would":[127],"occur":[128],"humans.An":[130],"overview":[131],"historic":[133],"pk/pd":[134],"models":[135],"presented":[137],"utility":[140],"relates":[149],"antibiotics":[151],"other":[153],"drugs":[154],"discussed.":[156]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}